DTC ad spending plummets by 18.4%

Advertising spending among pharmaceutical companies dropped 18.4 percent in 2008, from $5.3 billion to $4.3 billion, due in part to the bleak economic landscape and to a decrease in drugs on the market. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.